| # | Drug | Count |
|---|---|---|
| 0 | PANITUMUMAB | 934 |
| 1 | FLUOROURACIL | 794 |
| 2 | FLUOROURACIL CREAM, 0.5% | 794 |
| 3 | OXALIPLATIN | 706 |
| 4 | CARBOPLATIN | 483 |
| 5 | CAPECITABINE | 426 |
| 6 | PEMBROLIZUMAB | 403 |
| 7 | PACLITAXEL | 369 |
| 8 | CETUXIMAB | 363 |
| 9 | BEVACIZUMAB | 339 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PANITUMUMAB | 934 | 0.0580 |
| 1 | LAZERTINIB | 27 | 0.0312 |
| 2 | RYDAPT | 57 | 0.0291 |
| 3 | SODIUM HYPOCHLORITE | 7 | 0.0269 |
| 4 | DAUNORUBICIN HYDROCHLORIDE | 43 | 0.0261 |
| 5 | AMIVANTAMAB-VMJW | 89 | 0.0249 |
| 6 | COBIMETINIB | 94 | 0.0212 |
| 7 | TREOSULFAN | 52 | 0.0188 |
| 8 | CLOFARABINE | 40 | 0.0175 |
| 9 | DACOMITINIB | 11 | 0.0147 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 1315 |
| 1 | Platinum-based Drug [EPC] | 1291 |
| 2 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1257 |
| 3 | Kinase Inhibitor [EPC] | 911 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 710 |
| 5 | Microtubule Inhibitor [EPC] | 556 |
| 6 | Corticosteroid [EPC] | 478 |
| 7 | Alkylating Drug [EPC] | 441 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 360 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 355 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1257 | 0.0266 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 710 | 0.0072 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 1315 | 0.0048 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 28 | 0.0048 |
| 4 | Platinum-based Drug [EPC] | 1291 | 0.0047 |
| 5 | Gamma Secretase Inhibitor [EPC] | 4 | 0.0043 |
| 6 | Programmed Death Ligand-1 Blocker [EPC] | 82 | 0.0038 |
| 7 | Microtubule Inhibitor [EPC] | 556 | 0.0034 |
| 8 | Endoglycosidase [EPC] | 6 | 0.0032 |
| 9 | HER2/neu Receptor Antagonist [EPC] | 198 | 0.0026 |